Correspondence

Response to the ACMD's report on xylazine and related compounds

Government response to the report by the Advisory Council on the Misuse of Drugs on xylazine, medetomidine and detomidine.

• From: Home Office, Advisory Council on the Misuse of Drugs and The Rt Hon Chris Philp MP
• Published: 21 March 2024

This was published under the 2022 to 2024 Sunak Conservative government

Documents

Government response to the ACMD’s advice on xylazine and related compounds

HTML

Details

The government responds to a report by the Advisory Council on the Misuse of Drugs (ACMD) regarding the harms of xylazine and related compounds.

Published 21 March 2024